Cargando…
The Use of Tranexamic Acid to Prevent Postpartum Hemorrhage
Tranexamic acid (TXA) is an antifibrinolytic pharmacologic agent with demonstrated effectiveness for reducing the incidence of death from blood loss following trauma and major surgery. In intrapartum care, TXA is being used in in conjunction with uterotonic agents to treat postpartum hemorrhage (PPH...
Autores principales: | Mielke, Ruth T., Obermeyer, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383973/ https://www.ncbi.nlm.nih.gov/pubmed/32431098 http://dx.doi.org/10.1111/jmwh.13101 |
Ejemplares similares
-
Acceptability of intramuscular injection of tranexamic acid in postpartum hemorrhage prevention
por: Cordes, Sophia A., et al.
Publicado: (2023) -
Postpartum Hemorrhage and Tranexamic Acid: A Literature Review
por: Anaposala, Satvika, et al.
Publicado: (2023) -
Tranexamic acid for postpartum hemorrhage prevention in vaginal delivery: A meta-analysis
por: Xia, Yimeng, et al.
Publicado: (2020) -
Quality of oxytocin and tranexamic acid for the prevention and treatment of postpartum hemorrhage in Kenya, Nigeria, South Africa, and Tanzania
por: Ammerdorffer, Anne, et al.
Publicado: (2022) -
The cost‐effectiveness of tranexamic acid for treatment of postpartum hemorrhage: A systematic review
por: Aziz, Samia, et al.
Publicado: (2021)